Atazanavir-Mepha 300mg, Kapseln
7680663390033
CH-66339
Kapseln
Associated product:
ATAZANAVIR Mepha caps 300 mg bte 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
341.744 MG | Substance | WIZUS |
|
(N/A)
|
134.406 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 401.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/06/2019
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66339
- Drug name
- Atazanavir-Mepha, Kapseln
- Galenic form
- KAPS
- ATC Code
- J05AE08
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 19/09/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ATAZANAVIR Mepha caps 300 mg bte 30 pce
- Description (DE)
- ATAZANAVIR Mepha Kaps 300 mg Ds 30 Stk
- Market launch
- 19/09/2017
- Narcotic (BTM)
- No
Other package sizes (2)
None
60 KAP
GTIN: None
ATAZANAVIR Mepha caps 200 mg 60 pce
60 KAP
GTIN: 7680663390026